Neubase Therapeutics Inc (NBSE) stock is lower by -70.56% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives NBSE stock a score of 7 out of a possible 100.
That rank is influenced by a long-term technical score of 7. NBSE's rank also includes a short-term technical score of 15.
NBSE has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on NBSE!
Neubase Therapeutics Inc (NBSE) stock is up 119.23% while the S&P 500 is lower by -0.2% as of 1:20 PM on Thursday, Nov 30. NBSE has gained $0.77 from the previous closing price of $0.64 on volume of 6,216,168 shares. Over the past year the S&P 500 is up 11.31% while NBSE is lower by -70.56%. NBSE lost -$7.78 per share in the over the last 12 months.
Click Here to get the full Stock Report for Neubase Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
